Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-07

Study Completion Date

2019-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

RATIONALE: Studying samples of blood in the laboratory from patients with cancer and their relatives may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood samples collected from patients with Ewing sarcoma and their relatives.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Biomarkers in Tissue Samples From Patients With Ewing Sarcoma

NCT01480518

Sarcoma

COMPLETED

Collecting and Storing Biological Samples From Patients With Ewing Sarcoma

NCT00899990

Askin Tumor Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor +1 more

COMPLETED

Study of Tumor Samples From Patients With Ewing Sarcoma

NCT00898053

Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

COMPLETED

Biomarker in Tissue Samples From Patients With Ewing Sarcoma

NCT01365949

Sarcoma

COMPLETED

Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma

NCT01876303

Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

* To identify and characterize a genetic susceptibility factor to Ewing's sarcoma by performing a Genome-Wide Association Study with as many as possible Ewing sarcoma patients.

OUTLINE: This is a multicenter study.

Blood samples are collected from patients and their relatives. Blood DNA samples are analyzed for susceptibility genes of Ewing Sarcoma.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

FAMILY_BASED

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

genome-wide association study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

DISEASE CHARACTERISTICS:

* Patients with Ewing sarcoma
* Relatives of Ewing sarcoma patients

PATIENT CHARACTERISTICS:

* Patients with a fusion genes specific of Ewing Sarcoma

PRIOR CONCURRENT THERAPY:

* Not applicable

Minimum Eligible Age

0 Years

Maximum Eligible Age

120 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes